Literature DB >> 16047506

Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey.

Sheri L Maddigan1, David H Feeny, Jeffrey A Johnson.   

Abstract

OBJECTIVE: To assess the impact of comorbid heart disease, stroke and arthritis on health-related quality of life (HRQL) in people with diabetes in the general Canadian population.
METHODS: Data were collected as part of the 1996-1997 Canadian National Population Health Survey. HRQL was assessed using overall Health Utilities Index Mark 3 (HUI3) and single attribute utility scores. Respondents (N = 66,093) were classified into 1 of 16 groups based on the presence or absence of diabetes, heart disease, stroke, and arthritis, in all possible combinations and HRQL scores were compared using analysis of covariance.
RESULTS: Overall HUI3 scores for respondents with diabetes alone (0.88, 95% CI: 0.87-0.89) were lower than controls (0.92: 95% CI: 0.92-0.92, p < 0.001). Overall HUI3 scores for diabetes in combination with heart disease (0.77, 95% CI: 0.74-0.79), arthritis (0.78, 95% CI: 0.77-0.79) or stroke (0.79, 95% CI: 0.74-0.85) were considerably lower than diabetes alone. Triplets of comorbidities were associated with overall HRQL deficits of approximately 0.26-0.30, relative to controls.
CONCLUSIONS: The illness burden experienced by individuals with diabetes is not only associated with diabetes itself, but largely with comorbid medical conditions.

Entities:  

Mesh:

Year:  2005        PMID: 16047506     DOI: 10.1007/s11136-004-6640-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  40 in total

1.  Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications.

Authors:  J Hahl; H Hämäläinen; H Sintonen; T Simell; S Arinen; O Simell
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

2.  Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group.

Authors: 
Journal:  Diabetes Care       Date:  1999-07       Impact factor: 19.112

Review 3.  Quality of life and diabetes.

Authors:  R R Rubin; M Peyrot
Journal:  Diabetes Metab Res Rev       Date:  1999 May-Jun       Impact factor: 4.876

4.  Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey.

Authors:  P Grootendorst; D Feeny; W Furlong
Journal:  Med Care       Date:  2000-03       Impact factor: 2.983

5.  Valuing health-related quality of life in diabetes.

Authors:  J Todd Coffey; Michael Brandle; Honghong Zhou; Deanna Marriott; Ray Burke; Bahman P Tabaei; Michael M Engelgau; Robert M Kaplan; William H Herman
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

6.  Cardiac failure: symptoms and functional status.

Authors:  R Mayou; R Blackwood; B Bryant; J Garnham
Journal:  J Psychosom Res       Date:  1991       Impact factor: 3.006

7.  A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes.

Authors:  Sheri L Maddigan; David H Feeny; Jeffrey A Johnson
Journal:  Med Decis Making       Date:  2003 Nov-Dec       Impact factor: 2.583

Review 8.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

Review 9.  Health-related quality of life measurement in type 2 diabetes.

Authors:  F A Luscombe
Journal:  Value Health       Date:  2000 Nov-Dec       Impact factor: 5.725

10.  Health-related quality of life in type 2 diabetes (TARDIS-2).

Authors:  J Holmes; S McGill; P Kind; J Bottomley; S Gillam; M Murphy
Journal:  Value Health       Date:  2000 Nov-Dec       Impact factor: 5.725

View more
  73 in total

1.  Rethinking risk assessment for emerging technology first-in-human trials.

Authors:  Anna Genske; Sabrina Engel-Glatter
Journal:  Med Health Care Philos       Date:  2016-03

2.  Correlates of health-related quality of life in type 2 diabetes.

Authors:  D J Wexler; R W Grant; E Wittenberg; J L Bosch; E Cagliero; L Delahanty; M A Blais; J B Meigs
Journal:  Diabetologia       Date:  2006-04-29       Impact factor: 10.122

3.  Low risk of depression in diabetes? Would that it were so.

Authors:  Deborah J Wexler
Journal:  CMAJ       Date:  2006-07-04       Impact factor: 8.262

4.  Understanding the determinants of health for people with type 2 diabetes.

Authors:  Sheri L Maddigan; David H Feeny; Sumit R Majumdar; Karen B Farris; Jeffrey A Johnson
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

5.  Drug therapies for chronic hepatitis C infection: a cost-effectiveness analysis.

Authors:  William W L Wong; Karen M Lee; Sumeet Singh; George Wells; Jordan J Feld; Murray Krahn
Journal:  CMAJ Open       Date:  2017-02-03

6.  A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia.

Authors:  Nan Luo; Boon-Kheng Seng; Julian Thumboo; David Feeny; Shu-Chuen Li
Journal:  Qual Life Res       Date:  2006-06       Impact factor: 4.147

Review 7.  A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation.

Authors:  Tom W C Lung; Alison J Hayes; Andrew Hayen; Andrew Farmer; Philip M Clarke
Journal:  Qual Life Res       Date:  2011-04-07       Impact factor: 4.147

Review 8.  Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies.

Authors:  Katelijne van de Vooren; Silvy Duranti; Alessandro Curto; Livio Garattini
Journal:  Pharmacoeconomics       Date:  2014-01       Impact factor: 4.981

9.  Mental health and the relationship between health promotion counseling and health outcomes in chronic conditions: cross-sectional population-based study.

Authors:  Fatima Al Sayah; Calypse Agborsangaya; Markus Lahtinen; Tim Cooke; Jeffrey A Johnson
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

10.  Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens.

Authors:  Jeremy Chancellor; Samuel Aballéa; Alison Lawrence; Rob Sheldon; Sandrine Cure; Juliette Plun-Favreau; Nick Marchant
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.